Z-2381-2021Class II
EL-Anti-SARS-CoV-2 IgM Kit, Catalog #104-129, IVD. Submitted as EUA202129
Theratest Laboratories, Inc. / initiated 2020-07-30 / Terminated
Thera Test Laboratories, Inc. began a recall of EL-Anti-SARS-CoV-2 IgM Kit, Catalog #104-129, IVD. Submitted as EUA202129 on . FDA classified it as Class II and gives the reason as "Device did not meet the updated EUA packet requirements for positive percent agreement, thus, not adequately validated. Submitted as EUA202129". As of , the recall status on record is Terminated.
Recall record
- Recall number
- Z-2381-2021
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Theratest Laboratories, Inc.
- Product
- EL-Anti-SARS-CoV-2 IgM Kit, Catalog #104-129, IVD. Submitted as EUA202129
- Product code
- QKO Reagent, Coronavirus Serological
- Reason for recall
- Device did not meet the updated EUA packet requirements for positive percent agreement, thus, not adequately validated. Submitted as EUA202129
- FDA root cause
- No Marketing Application
- Action
- An undated letter was issued to their customers attached to an email dated 7/30/2020 explaining the reason for recall and requesting the customer stop testing with the kit.
- Quantity in commerce
- 11 kits
- Distribution
- US Nationwide distribution in the states of CA, FL, IL, IN, NC, and TX.
- Product codes and lots
- Kit lot numbers 05204350, exp. 05/01/2021; 05204367, exp. 05/19/2021; and 06204432, exp. 05/19/2021.
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-2381-2021 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
